Noninvasive prostate treatment developed

Key points
- Computed tomography is an effective noninvasive method for locating the prostatic apex for radiation therapy for prostate cancer, U.S. researchers say.
- Gregory Swanson of the University of Texas Health Science Center at San Antonio said retrograde urethrography, which involves inserting a catheter into the male urethra to inject contrast, is the standard method used to identify the area of the prostate to be treated with radiation.
- However, this method is invasive and uncomfortable for patients and comes with risks of side effects, such as urethral injury and infection, as well as additional costs, Swanson said.
- Fifteen patients underwent a CT simulation both with and without bladder, urethral and rectal contrast.
Computed tomography is an effective noninvasive method for locating the prostatic apex for radiation therapy for prostate cancer, U.S. researchers say.
Dr. Gregory Swanson of the University of Texas Health Science Center at San Antonio said retrograde urethrography, which involves inserting a catheter into the male urethra to inject contrast, is the standard method used to identify the area of the prostate to be treated with radiation.
However, this method is invasive and uncomfortable for patients and comes with risks of side effects, such as urethral injury and infection, as well as additional costs, Swanson said.
Fifteen patients underwent a CT simulation both with and without bladder, urethral and rectal contrast. The prostatic base and apex were identified easily and consistently on both scans by taking a side view of the patient and drawing a line from the pubic bone straight down to the floor of the pelvis.
The study, published in the International Journal of Radiation Oncology*Biology*Physics, said the process was repeated and confirmed in another 57 patients, leading researchers to determine that it is not necessary to subject a patient to a urinary catheter for contrast delivery.
SAN ANTONIO, May 22 (UPI)
© 2008 United Press International. All Rights Reserved.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsMoffitt Cancer Center Researcher Helps Develop Prostate Cancer Testing, Treatment Guidelines
Julio M. Pow-Sang, M.D., chair of Moffitt Cancer Center's Department of Genitourinary Oncology, and colleagues have published two prostate cancer articles in the September issue of JNCCN - The Journal of the National…
29 September 2012
NewsCloned receptor paves way for new breast and prostate cancer treatment
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the…
14 September 2012
NewsMore men with prostate cancer "team" wait on treatment
Men with low-risk forms of prostate cancer are more likely to opt for so-called active surveillance over surgery or radiation when they have a multidisciplinary team of doctors working with them, according to a new…




